GIUSEPPE DI BELLA > NEWS > null > null > La Vitamina E nelle malattie linfoproliferative

 
La Vitamina E nelle malattie linfoproliferative di S.I.B.O.R. - M.D.B.
 
 
Data: 14/07/2006
Tipologia: MDB - Documentazione
Lingua: Italiano
Anno: 2006
 
 
Descrizione:

PER LEGGERE E SCARICARE IL CAPITOLO SULLA VITAMINA E, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 41 pagine in formato PDF e pesa 177 kb.



BIBLIOGRAFIA

per leggere gli abstract di ogni fonte, cliccare sul titolo del lavoro





Azzi, A., R. Gysin, et al. (2003). "The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events." Mol Aspects Med 24(6): 325-36.







Brigelius-Flohe, R. and M. G. Traber (1999). "Vitamin E: function and metabolism." Faseb J 13(10): 1145-55.







Dalen, H. and J. Neuzil (2003). "Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation." Br J Cancer 88(1): 153-8.







Elattar, T. M. and A. S. Virji (1999). "Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells." Anticancer Res 19(1A): 365-8.







Fang, Y. Z., S. Yang, et al. (2002). "Free radicals, antioxidants, and nutrition." Nutrition 18(10): 872-9.







Fariss, M. W., M. B. Fortuna, et al. (1994). "The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds." Cancer Res 54(13): 3346-51.







Heisler, T., S. Towfigh, et al. (2000). "Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth." J Surg Res 88(1): 23-5.







Hensley, K., E. J. Benaksas, et al. (2004). "New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine." Free Radic Biol Med 36(1): 1-15.







Huang, H. Y., A. J. Alberg, et al. (2003). "Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer." Am J Epidemiol 157(4): 335-44.







Inokuchi, H., H. Hirokane, et al. (2003). "Anti-angiogenic activity of tocotrienol." Biosci Biotechnol Biochem 67(7): 1623-7.







Israel, K., W. Yu, et al. (2000). "Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis." Nutr Cancer 36(1): 90-100.







Jiang, Q., S. Christen, et al. (2001). "gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention." Am J Clin Nutr 74(6): 714-22.







Malafa, M. P., F. D. Fokum, et al. (2002). "Vitamin E inhibits melanoma growth in mice." Surgery 131(1): 85-91.







Malafa, M. P. and L. T. Neitzel (2000). "Vitamin E succinate promotes breast cancer tumor dormancy." J Surg Res 93(1): 163-70.







Miyazawa, T., T. Tsuzuki, et al. (2004). "Antiangiogenic potency of vitamin E." Ann N Y Acad Sci 1031: 401-4.







Neuzil, J., K. Kagedal, et al. (2002). "Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity." Apoptosis 7(2): 179-87.







Neuzil, J., T. Weber, et al. (2001). "Selective cancer cell killing by alpha-tocopheryl succinate." Br J Cancer 84(1): 87-9.







Prasad, K. N., R. J. Cohrs, et al. (1990). "Decreased expressions of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture." Biochem Cell Biol 68(11): 1250-5.







Prasad, K. N., C. Hernandez, et al. (1994). "Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins." Nutr Cancer 22(3): 233-45.







Prasad, K. N., B. Kumar, et al. (2003). "Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review." J Am Coll Nutr 22(2): 108-17.







Prasad, K. N. and R. Kumar (1996). "Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in culture." Nutr Cancer 26(1): 11-9.







Pussinen, P. J., H. Lindner, et al. (2000). "Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells." Biochim Biophys Acta 1485(2-3): 129-44.







Ricciarelli, R., J. M. Zingg, et al. (2001). "Vitamin E: protective role of a Janus molecule." Faseb J 15(13): 2314-25.







Ripoll, E. A., B. N. Rama, et al. (1986). "Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro." J Urol 136(2): 529-31.







Rose, A. T. and D. W. McFadden (2001). "Alpha-tocopherol succinate inhibits growth of gastric cancer cells in vitro." J Surg Res 95(1): 19-22.







Sarna, S., A. Kumar, et al. (2000). "alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)." Braz J Med Biol Res 33(8): 929-36.







Shklar, G. and J. L. Schwartz (1996). "Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis." Eur J Cancer B Oral Oncol 32B(2): 114-9.







Tang, F. Y. and M. Meydani (2001). "Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production." Nutr Cancer 41(1-2): 119-25.







Turley, J. M., S. Funakoshi, et al. (1995). "Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta." Cell Growth Differ 6(6): 655-63.







Wu, K., Y. Zhao, et al. (2002). "RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest." World J Gastroenterol 8(1): 26-30.







Yu, A., P. Somasundar, et al. (2002). "Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor." J Surg Res 105(1): 65-8.







Yu, W., K. Israel, et al. (1999). "Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis." Cancer Res 59(4): 953-61.







Yu, W., Q. Y. Liao, et al. (2001). "Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells." Cancer Res 61(17): 6569-76.







Yu, W., B. G. Sanders, et al. (1997). "RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest." Nutr Cancer 27(1): 92-101.







Zhang, Y., J. Ni, et al. (2002). "Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells." Proc Natl Acad Sci U S A 99(11): 7408-13.

 
 
 

PER LEGGERE E SCARICARE IL CAPITOLO SULLA VITAMINA E, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 41 pagine in formato PDF e pesa 177 kb.



BIBLIOGRAFIA

per leggere gli abstract di ogni fonte, cliccare sul titolo del lavoro





Azzi, A., R. Gysin, et al. (2003). "The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events." Mol Aspects Med 24(6): 325-36.







Brigelius-Flohe, R. and M. G. Traber (1999). "Vitamin E: function and metabolism." Faseb J 13(10): 1145-55.







Dalen, H. and J. Neuzil (2003). "Alpha-tocopheryl succinate sensitises a T lymphoma cell line to TRAIL-induced apoptosis by suppressing NF-kappaB activation." Br J Cancer 88(1): 153-8.







Elattar, T. M. and A. S. Virji (1999). "Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells." Anticancer Res 19(1A): 365-8.







Fang, Y. Z., S. Yang, et al. (2002). "Free radicals, antioxidants, and nutrition." Nutrition 18(10): 872-9.







Fariss, M. W., M. B. Fortuna, et al. (1994). "The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds." Cancer Res 54(13): 3346-51.







Heisler, T., S. Towfigh, et al. (2000). "Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth." J Surg Res 88(1): 23-5.







Hensley, K., E. J. Benaksas, et al. (2004). "New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine." Free Radic Biol Med 36(1): 1-15.







Huang, H. Y., A. J. Alberg, et al. (2003). "Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer." Am J Epidemiol 157(4): 335-44.







Inokuchi, H., H. Hirokane, et al. (2003). "Anti-angiogenic activity of tocotrienol." Biosci Biotechnol Biochem 67(7): 1623-7.







Israel, K., W. Yu, et al. (2000). "Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis." Nutr Cancer 36(1): 90-100.







Jiang, Q., S. Christen, et al. (2001). "gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention." Am J Clin Nutr 74(6): 714-22.







Malafa, M. P., F. D. Fokum, et al. (2002). "Vitamin E inhibits melanoma growth in mice." Surgery 131(1): 85-91.







Malafa, M. P. and L. T. Neitzel (2000). "Vitamin E succinate promotes breast cancer tumor dormancy." J Surg Res 93(1): 163-70.







Miyazawa, T., T. Tsuzuki, et al. (2004). "Antiangiogenic potency of vitamin E." Ann N Y Acad Sci 1031: 401-4.







Neuzil, J., K. Kagedal, et al. (2002). "Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity." Apoptosis 7(2): 179-87.







Neuzil, J., T. Weber, et al. (2001). "Selective cancer cell killing by alpha-tocopheryl succinate." Br J Cancer 84(1): 87-9.







Prasad, K. N., R. J. Cohrs, et al. (1990). "Decreased expressions of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture." Biochem Cell Biol 68(11): 1250-5.







Prasad, K. N., C. Hernandez, et al. (1994). "Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins." Nutr Cancer 22(3): 233-45.







Prasad, K. N., B. Kumar, et al. (2003). "Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review." J Am Coll Nutr 22(2): 108-17.







Prasad, K. N. and R. Kumar (1996). "Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in culture." Nutr Cancer 26(1): 11-9.







Pussinen, P. J., H. Lindner, et al. (2000). "Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells." Biochim Biophys Acta 1485(2-3): 129-44.







Ricciarelli, R., J. M. Zingg, et al. (2001). "Vitamin E: protective role of a Janus molecule." Faseb J 15(13): 2314-25.







Ripoll, E. A., B. N. Rama, et al. (1986). "Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro." J Urol 136(2): 529-31.







Rose, A. T. and D. W. McFadden (2001). "Alpha-tocopherol succinate inhibits growth of gastric cancer cells in vitro." J Surg Res 95(1): 19-22.







Sarna, S., A. Kumar, et al. (2000). "alpha-Tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II)." Braz J Med Biol Res 33(8): 929-36.







Shklar, G. and J. L. Schwartz (1996). "Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis." Eur J Cancer B Oral Oncol 32B(2): 114-9.







Tang, F. Y. and M. Meydani (2001). "Green tea catechins and vitamin E inhibit angiogenesis of human microvascular endothelial cells through suppression of IL-8 production." Nutr Cancer 41(1-2): 119-25.







Turley, J. M., S. Funakoshi, et al. (1995). "Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta." Cell Growth Differ 6(6): 655-63.







Wu, K., Y. Zhao, et al. (2002). "RRR-alpha-tocopheryl succinate inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest." World J Gastroenterol 8(1): 26-30.







Yu, A., P. Somasundar, et al. (2002). "Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor." J Surg Res 105(1): 65-8.







Yu, W., K. Israel, et al. (1999). "Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis." Cancer Res 59(4): 953-61.







Yu, W., Q. Y. Liao, et al. (2001). "Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells." Cancer Res 61(17): 6569-76.







Yu, W., B. G. Sanders, et al. (1997). "RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest." Nutr Cancer 27(1): 92-101.







Zhang, Y., J. Ni, et al. (2002). "Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells." Proc Natl Acad Sci U S A 99(11): 7408-13.

 
 
 

 

Documento Allegato

Stampa